Free CME from PeerView


Neurology CME

Benjamin M. Greenberg, MD, MHS / Professor Anthony Traboulsee, MD
Credits: 1.0 CME / NCPD / CPE
Medical Learning Institute, Inc.
Bruton Tyrosine Kinase Inhibitors for MS: Progress in the Development of an Emerging Therapeutic Approach
October 28, 2021
Bruce Cree, MD, PhD, MAS
Credits: 1 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Exploring the Convergence of Advances in S1P Receptor Modulation With Progress in Understanding Brain Atrophy and Cognition Measures in Multiple Sclerosis
October 25, 2021
Credits: 0.5 CME
Medical Learning Institute, Inc.
On the Cusp of a New Targeted Treatment Era in ALS: Exploring the Emerging Therapeutic Landscape
October 21, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
The Dawn of a New Era: Recent Advances in the Pharmacologic Management of Idiopathic Hypersomnia
June 25, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Managing Motor Complications in Parkinson’s Disease: Evaluating the Role of On-Demand Therapies for “Off” Episodes
June 22, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Advancing the Treatment of Pompe Disease: Clinical Updates in Newborn Screening and Enzyme Replacement
June 10, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
A Visual Exploration of Antisense Oligonucleotide Therapies in Amyotrophic Lateral Sclerosis
June 8, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
The Evolving Role of Oxybate Agents in the Management of Narcolepsy: A Visual Exploration of Individualized Care
May 18, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
A New Era of Migraine Management: Recent Updates on Recognition, Acute Treatment, and Prevention for Emergency Physicians
May 3, 2021
Credits: 1.00 CME
Medical Learning Institute, Inc.
Applying Evidence to Practice: Updated Consensus Recommendations for the Diagnosis, Surveillance, and Management of Tuberous Sclerosis Complex
April 14, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
Data-Based Updates: Practical Application of Recent Evidence on Disease-Modifying Therapies for SMA
March 30, 2021
Credits: 0.50 CME
Penn State College of Medicine
A Visual Guide to B-Cell Therapies in Relapsing MS: Clarifying the Options in an Expanding Treatment Landscape
March 26, 2021
Credits: 1.00 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Expert Perspectives on the Early Diagnosis of Alzheimer’s Disease and the Promise of Novel Therapies on the Horizon
March 22, 2021
Anne H. Cross, MD, FAAN / Prof. Xavier Montalban
Credits: 1.00 CME / NCPD / CPE
Medical Learning Institute, Inc.
Exploring the Rationale, Results, and Real-World Clinical Potential of BTK Inhibitors in the Management of Multiple Sclerosis
February 1, 2021
Credits: 0.50 CME
Medical Learning Institute, Inc.
MS Treatment Decisions Before, During, and After Pregnancy: Focus on the Use of Disease-Modifying Therapies
January 22, 2021
Credits: 0.25 CME
Medical Learning Institute, Inc.
Provider Perspectives on Current and Emerging Disease-Modifying Treatments for Multiple Sclerosis
December 31, 2020
Credits: 0.50 CME
Medical Learning Institute, Inc.
Improving Outcomes in ALS Through Early Diagnosis and Emerging Targeted Therapies
December 31, 2020
Credits: 1.50 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Targeting the RAS/MAPK Pathway in Neurofibromatosis Type 1 and Plexiform Neurofibromas: Improving Patient Outcomes With an Innovative Therapeutic Approach
December 18, 2020
PeerView Institute
Advances in the Treatment of Alzheimer’s Disease: Preparing for a Shift in the Treatment Paradigm
November 24, 2020
Johns Hopkins University School of Medicine
Not So FAST: Improving the Diagnosis and Treatment of Posterior Circulation Stroke
November 13, 2020
Orrin Devinsky, MD / Sheldon J. Rich, RPh, PhD
Purdue University College of Pharmacy
Cannabidiol in the Treatment Arsenal for Severe Epilepsy Syndromes: Practical Guidance for Managed Care Professionals
November 13, 2020
Medical Learning Institute, Inc.
Addressing Unmet Needs in the Acute Treatment of Migraine: Focus on the Role of the 5-HT1F Receptor
October 21, 2020
Medical Learning Institute, Inc.
Finding the Path to Improved Recognition and Management of Tardive Dyskinesia
September 28, 2020
Concetta (Connie) DiDomenico, RN, MSN, PNP-BC, CPHON / Michael J. Fisher, MD
Medical Learning Institute, Inc.
Targeting the RAS/MAPK Pathway in Neurofibromatosis Type 1, Plexiform Neurofibromas, and Optic Pathway Gliomas: Improving Patient Outcomes With an Innovative Therapeutic Approach
September 24, 2020
Medical Learning Institute, Inc.
Exploring Current Guidelines and Emerging Therapeutic Strategies for the Treatment of Dementia-Related Psychosis
September 15, 2020

Pages